Logan Lutton

Here’s what you missed this week on Managed Healthcare Executive.

Keri Althoff, Ph.D., discusses how a model developed at Johns Hopkins can assess the comorbidities that patients with HIV may face by 2030.

Improving equity for people with HIV requires health leaders to recognize that patients have different risk factors, Keri Althoff, Ph.D., of Johns Hopkins says.

An overview of the complex relationships between herpes simplex virus, human papillomavirus, cytomegalovirus and HIV.

Younger transgender and gender diverse individuals see a greater stigma around PrEP, but experts are still unsure why.

When it comes to preventing and treating patients with HIV/AIDS, experts say to look towards the youth.

Inequalities throughout the world in treatment and prevention of HIV are not being addressed, with infection rates rising in the Middle East and north Africa, Eastern Europe and central Asia and Latin America.

Here’s what you missed this week on Managed Healthcare Executive.

Part two focuses on the requirement that Part D sponsors must make enrollees aware of upcoming benefits.

American Indian and Alaska Native women also had higher comorbidities and less access to private insurance than White women.

How Long COVID-19 rates differ across the pre-delta, delta and omicron eras.

Dr. Charles C. Wykoff discusses how a one-time gene therapy could benefit patients with wet age-related macular degeneration.

Dr. Charles C. Wykoff discusses interim results from a phase 2 trial of a gene therapy to treat with patients with wet age-related macular degeneration.

Grandmother and great-grandmother Donna Osborne had recently finished radiation therapy when she won the prize.

: A Taiwanese study builds upon previous contradictory research exploring the link between breast cancer and acute myocardial infarction.

Here’s what you missed this week on Managed Healthcare Executive.

The St. Louis-based center will serve as a base where researchers and public health experts can fight the HIV epidemic together.

This is good news for developing an HIV vaccine because previous research had indicated it could take years for these antibodies to appear.

A breakdown of recent survey results revealing which benefits employers plan to keep and what they are looking to add in 2025.

Ohtuvayre - an inhaled bronchodilator with non-steroidal anti-inflammatory effects - is the first new mechanism in COPD approved in more than 20 years.

Previous acupuncture studies have focused on European and American women, but little was known about breast cancer patients in Asia.

The CMS released its projections earlier this month, saying healthcare spending will hit $7.7 trillion by 2032.

Women with HIV are more affected by stigma, gender inequality and socioeconomic status when compared to men with HIV.

EndeavorOTC costs $24.99 monthly or $129.99 annually.

A recent industry survey conducted by HealthEdge provides insight into how health insurance consumers in the United States feel about their current coverage.

The same is not true for Black women, who are 40% more likely to die from breast cancer than white women, suggesting other factors are to blame.

Even though value-based care has been talked about for a long time, it may not be the end.

In 2024, there have been two common health plan issues brought up by employers.

Type 2 diabetes patients ages 10 and up can now take Farxiga.

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about how GLP-1 agonist drugs like Wegovy and Zepbound are changing the paradigm for weight loss.